ES8606296A1 - Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida - Google Patents

Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida

Info

Publication number
ES8606296A1
ES8606296A1 ES538829A ES538829A ES8606296A1 ES 8606296 A1 ES8606296 A1 ES 8606296A1 ES 538829 A ES538829 A ES 538829A ES 538829 A ES538829 A ES 538829A ES 8606296 A1 ES8606296 A1 ES 8606296A1
Authority
ES
Spain
Prior art keywords
leukemia
hydrogen
pyrimidinecarboxamides
fluoro
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538829A
Other languages
English (en)
Other versions
ES538829A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIROYAL Ltd
Uniroyal Inc
Original Assignee
UNIROYAL Ltd
Uniroyal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIROYAL Ltd, Uniroyal Inc filed Critical UNIROYAL Ltd
Publication of ES8606296A1 publication Critical patent/ES8606296A1/es
Publication of ES538829A0 publication Critical patent/ES538829A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA 5-PIRIMIDINCARBOXAMIDA O TIOCARBOXAMIDA, DE FORMULA GENERAL (1), EN LA QUE R5 Y R6 PUEDEN SER CADA UNO DE ELLOS INDEPENDIENTEMENTE HIDROGENO O UN RESIDUO CARBOHIDRATO; R3 ES HIDROGENO O ALQUILO; R4 ES FENILO, NAFTILO O BENCILO; W ES OXIGENO O AZUFRE; X ES AZUFRE O SELENIO; E Y Y Z PUEDEN SER CADA UNO DE ELLOS INDEPENDIENTEMENTE OXIGENO, AZUFRE O SELENIO, Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN ACIDO 2-TIOBARBITURICO CON UN ISOCIANATO O ISOTIOCIANATO DE FORMULA GENERAL: R4 C N F C F W, EN PRESENCIA DE UN MEDIO DISOLVENTE O DISPERSANTE. DE APLICACION COMO AGENTE ANTI-CANCERIGENO POTENCIAL, UTILIZADO EN EL TRATAMIENTO DE LA LEUCEMIA Y DE LOS TUMORES.
ES538829A 1983-12-19 1984-12-19 Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida Expired ES8606296A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US66526784A 1984-10-26 1984-10-26
US66520184A 1984-10-26 1984-10-26

Publications (2)

Publication Number Publication Date
ES8606296A1 true ES8606296A1 (es) 1986-04-16
ES538829A0 ES538829A0 (es) 1986-04-16

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538829A Expired ES8606296A1 (es) 1983-12-19 1984-12-19 Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida

Country Status (19)

Country Link
US (1) US4634707A (es)
JP (1) JPH0660164B2 (es)
AT (1) AT394194B (es)
AU (1) AU580746B2 (es)
BE (1) BE901301A (es)
CH (1) CH671225A5 (es)
DE (1) DE3446371A1 (es)
DK (1) DK164055C (es)
ES (1) ES8606296A1 (es)
FR (1) FR2557108B1 (es)
GB (1) GB2152047B (es)
GR (1) GR82494B (es)
IE (1) IE57675B1 (es)
IL (1) IL73840A (es)
IT (1) IT1213257B (es)
LU (1) LU85696A1 (es)
NL (1) NL8403856A (es)
NZ (2) NZ220399A (es)
SE (1) SE469171B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
PH24423A (en) * 1985-02-15 1990-06-25 Ciba Geigy Ag 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
AU7540991A (en) * 1990-03-09 1991-10-10 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
JP2003531196A (ja) * 2000-04-24 2003-10-21 アリックス セラピューティクス 超短時間作用型催眠性バルビツール酸塩
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
WO2016118611A1 (en) * 2015-01-22 2016-07-28 Warrell Raymond P Jr Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
CA3029883A1 (en) 2016-07-06 2018-01-11 Acquist Llc Compounds and their use for reducing uric acid levels
IT201700028709A1 (it) 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
DE2962834D1 (en) * 1978-10-30 1982-07-01 Fujisawa Pharmaceutical Co 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
GB8431832D0 (en) * 1983-12-19 1985-01-30 Uniroyal Inc 5-pyrimidinecarboxamides
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
JPS641445A (en) 1987-06-22 1989-01-05 Toshiba Corp Manufacture of stator coil

Also Published As

Publication number Publication date
NZ210599A (en) 1987-09-30
IL73840A (en) 1988-11-15
FR2557108A1 (fr) 1985-06-28
DK164055B (da) 1992-05-04
DK164055C (da) 1992-09-28
BE901301A (fr) 1985-06-18
CH671225A5 (es) 1989-08-15
US4634707A (en) 1987-01-06
NL8403856A (nl) 1985-07-16
ATA402684A (de) 1991-08-15
GB8432112D0 (en) 1985-01-30
JPS62174058A (ja) 1987-07-30
SE8406450D0 (sv) 1984-12-18
IT8424104A0 (it) 1984-12-18
IE843237L (en) 1985-06-19
ES538829A0 (es) 1986-04-16
AT394194B (de) 1992-02-10
SE469171B (sv) 1993-05-24
GB2152047A (en) 1985-07-31
IE57675B1 (en) 1993-02-24
AU3690884A (en) 1985-07-04
SE8406450L (sv) 1985-06-20
DE3446371C2 (es) 1990-08-16
DK609184D0 (da) 1984-12-18
JPH0660164B2 (ja) 1994-08-10
DK609184A (da) 1985-06-20
IT1213257B (it) 1989-12-14
AU580746B2 (en) 1989-02-02
GR82494B (en) 1985-04-19
IL73840A0 (en) 1985-03-31
NZ220399A (en) 1987-09-30
LU85696A1 (fr) 1985-09-12
GB2152047B (en) 1988-04-27
DE3446371A1 (de) 1985-06-27
FR2557108B1 (fr) 1988-11-18

Similar Documents

Publication Publication Date Title
ES8606296A1 (es) Procedimiento para la preparacion de una 5-pirimidincarboxamida o tiocarboxamida
TW222636B (es)
AU5216586A (en) Arylaminoalkyl- and aryloxyalkyl guanidines
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
AU3484389A (en) 6-phenyl-3(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives, their preparation and their application in therapy
HUT39182A (en) Process for producing carbapeneme compounds
CY1679A (en) Stabilization of antibiotic compositions with salts
ES8800671A1 (es) Procedimiento para preparar 5-pirimidin-carboxamidas sustituidas con actividad anti-leucemia
AU4978690A (en) 2-amino-7-hydroxytetralin carboxyalkyl ethers
ES8402288A1 (es) Proceso de produccion de los derivados de la piperacina.
YU227886A (en) Process for obtaining monosulphactame
ATE36539T1 (de) Antitumor-anthracycline.
AU8503191A (en) Azeotrope-like compositions of 1,1-dichloro-1-fluoroethane; dichlorotrifluoroethane; methanol; and alkene having 5 carbon atoms
ES8406507A1 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
CA1269370C (en) SULFONO AND SULFOXO ANALOGS OF DAUNOMYCIN AND ADRIAMYCIN
ES8801636A1 (es) Un procedimiento para preparar nuevos derivados de imidazol
DE3464602D1 (en) 4-alkylimidazole derivatives, their preparation and their application
ES2004384A6 (es) Procedimiento para preparar compuestos antibioticos macrolidos y metodo para combatir plagas con ellos.
GB9915069D0 (en) New indolocarbazole alkaloids from a marine actinomycete
ES8707489A1 (es) Un procedimiento para preparar un derivado de carbaciclina
ES8605498A1 (es) Procedimiento de preparacion de nuevos derivados (2-alcoxi) fenilpiperazinicos y de sus sales de adicion acidas farma- ceuticamente aceptables
ES469999A1 (es) Procedimiento de preparar nuevos derivados de 5,6-dihidroi- midazo(5,1-a)isoquinolina
PT78325B (en) Process for preparing novel macrolides ptl-448
GR3017990T3 (en) Isoindoles having cardiovascular activity.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503